Current therapy of sickle cell disease.
Aliyu
Zakari Y
ZY
Tumblin
Ashaunta R
AR
Kato
Gregory J
GJ
D000081:Acetamides / Q000627:therapeutic use; D000755:Anemia, Sickle Cell / Q000628:therapy*; D001374:Azacitidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D002087:Butyrates / Q000627:therapeutic use; D000077209:Decitabine; D017707:Erythrocyte Transfusion; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D009569:Nitric Oxide / Q000627:therapeutic use; D014320:Triphenylmethyl Compounds / Q000627:therapeutic use
D000081:Acetamides; D002087:Butyrates; D014320:Triphenylmethyl Compounds; D009569:Nitric Oxide; D000077209:Decitabine; D001374:Azacitidine; C472774:senicapoc; D006918:Hydroxyurea